ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Similar documents
«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Low Gradient Severe? AS

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Indicator Mild Moderate Severe

Aortic Valve Replacement Improves Outcome in Patients with Preserved Ejection Fraction: PRO!

ECHO HAWAII. My home. Pulmonary Hypertension and Pulmonary Embolism: Role of Echo U.S.A. Japan. Hawaii Island 1/9/2018

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

Aortic Valve Stenosis: Flow and Gradient stratification and association with TAVR outcomes

Sténose aortique à Bas Débit et Bas Gradient

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

TAVR: Echo Measurements Pre, Post And Intra Procedure

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Valvular Guidelines: The Past, the Present, the Future

Managing the Low Output Low Gradient Aortic Stenosis Patient

Low Gradient AS: Multi-Imaging Modalities

Stress Testing in Valvular Disease

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Spotlight on Valvular Heart Disease Guidelines

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Usually we DON T need to go beyond the gradient

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Low gradient severe aortic stenosis with preserved left ventricular ejection fraction

Echocardiographic evaluation of mitral stenosis

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

The best in heart valve disease Aortic valve stenosis

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016

Natural History and Echo Evaluation of Aortic Stenosis

Aortic stenosis aetiology: morphology of calcific AS,

Prosthetic valve dysfunction: stenosis or regurgitation

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Comprehensive Echo Assessment of Aortic Stenosis

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece

Paradoxical low flow-low gradient severe aortic stenosis: where are we?

Exercise PHT in valvular heart disease. Julien Magne CHU Limoges, France

Affecting the elderly Requiring new approaches. Echocardiographic Evaluation of Hemodynamic Severity. Increasing prevalence Mostly degenerative

Aortic Valvular Stenosis

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

History of Stress Testing. Disclosure. Overview. Stress Echocardiography New Applications. and Comparison with Other Stress.

The difficult patient with mitral regurgitation

A Practical Approach to Prosthetic Valves

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

Michigan Society of Echocardiography 30 th Year Jubilee

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

10/1/2016. Constrictive Pericarditis Unique Hemodynamics. What s New in Pericardial Disease? Case-based Discussion

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

How to assess ischaemic MR?

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

New Imaging for Aortic Valve Disease. Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego

Cardiovascular Imaging Stress Echo

When Does 3D Echo Make A Difference?

Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

Swan Song: Echocardiography as a Pulmonary Artery Catheter? Interdepartmental Division of Critical Care Medicine

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Prognostic Value of Left Atrial Size and Function

Choose the grading of diastolic function in 82 yo woman

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Reverse left atrium and left ventricle remodeling after aortic valve interventions

Aortic Stenosis.

Disclosures. Stress Echocardiography 2010 Appropriate Use & Further Applications. Stress Echo Clinical Utility 9/8/10

Aortic stenosis with concomitant mitral regurgitation

Constriction vs Restriction Case-based Discussion

Nothing to Disclose. Questions. Disclosure Asymptomatic Severe Aortic Stenosis: (When) Should One Intervene? Paul Wood at the Nathanson Lecture, 1958

Value of echocardiography in chronic dyspnea

Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ;

Diastolic Function Assessment New Guideline Update Practical Approach

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong

Relevant Financial Relationship(s) Off Label Usage. None. None

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

Valvular Heart Disease: Assessment and Timing of Intervention. Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust

HFpEF. April 26, 2018

What the Cardiologist needs to know from Medical Images

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Exercise Testing/Echocardiography in Asymptomatic AS

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Ref 1. Ref 2. Ref 3. Ref 4. See graph

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

Aortic Stenosis Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Valvular disease : Ο ρόλος του CMR. Sophie Mavrogeni MD FESC. Onassis Cardiac Surgery Center Athens Greece

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

Worldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates

Constrictive Pericarditis

Valvular Heart Disease

Echocardiographic Evaluation of Aortic Valve Prosthesis

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

TAVR in patients with. End-Stage CKD or in Renal Replacement Therapy:

Severity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root

Clinical Outcome in Patients with Aortic Stenosis

Transcription:

Role of Stress Echo in Valvular Heart Disease ECHO HAWAII January 15 19, 2018 Kenya Kusunose, MD, PhD, FASE Tokushima University Hospital Japan Not only ischemia! Cardiomyopathy Prosthetic Valve Diastolic Dysfunction Pulmonary hypertension Valvular Heart Disease 1

Not only ischemia! Valvular Heart Disease Mitral regurgitation Mitral stenosis Aortic stenosis Aortic regurgitation Case 1 68 y.o. male With a history of hypertension and mitral regurgitation. He presented for a second opinion regarding surgical management of mitral regurgitation. He had no symptom during any activities. 2

Case 1 Moderate to severe MR Case 1 TEE 3

Case 1 Question 1 68 y.o. asymptomatic male with moderate to severe MR Your recommendation is 1. Surgical MV repair 2. Percutaneous MV replacement 3. Anticoagulation therapy 4. Stress echocardiography 4

Question 1 68 y.o. asymptomatic male with moderate to severe MR Your recommendation is 1. Surgical MV repair 2. Percutaneous MV replacement 3. Anticoagulation therapy 4. Stress echocardiography Baseline 5

25W 50W (peak) 6

Pre Doppler Peak SPAP: 37 mmhg SPAP: 60 mmhg MR severity Pre Peak PISA radius: 6 mm PISA radius: 10 mm 7

Summary Exercise induced pulmonary hypertension: SPAP: 60 mmhg Significant increase in simple PISA radius from 6 mm to 10 mm (Severe MR) Good contractile reserve: EF 62 74% Symptom was occurred during exercise. Recommendation is Decision Surgery (repair if low risk) 8

2017 updated ACC/AHA Guideline Nishimura RA et al. J Am Coll Cardiol. 2017 Jul 11;70(2):252 289. Stress Echocardiography and Mitral Regurgitation Exercise ESVI and Post operative EF 74 patients with severe MR who underwent exercise echocardiography and mitral valve surgery. Leung DY et al. J Am Coll Cardiol. 1996 Nov 1;28(5):1198 205. 9

Prognostic Importance of Exercise-Induced Changes in Mitral regurgitation 98 consecutive patients with MR who underwent exercise echocardiography. No significant change in MR Increase in MR Increase in MR Lancellotti P et al. Circulation. 2003 Oct 7;108(14):1713 7. Predictors of outcomes in Patients with MR undergoing exercise echocardiography 196 consecutive patients with moderate to severe MR who underwent exercise echocardiography. Event-free survival (%) 100 80 60 Log-rank test P <0.001 PH (-) and RV dysfunction (-) 40 20 PH (+) and RV dysfunction (+) 0 0 12 24 36 48 Follow-up, months Kusunose K et al. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):167 76. 10

Mitral regurgitation Cut off MR grade: an increase by 1 grade Systolic pulmonary artery pressure: 60 mmhg Contractile reserve: 5% increase in EF J Am Soc Echocardiogr. 2017 Feb;30(2):101 138. doi: 10.1016/j.echo.2016.10.016. Case 2 72 y.o. female With a history of hypertension and mitral stenosis. She presented for a second opinion regarding management of mitral stenosis. She noted a slight fatigue. 11

Case 2 Wall motion: normal Mitral stenosis MVA: 1.7 cm 2 12

Mitral stenosis Mean PG: 5.7 mmhg SPAP: 33 mmhg Question 2 72 y.o. mild symptomatic female with moderate MS Your recommendation is 1. Cardiac CT 2. Coronary angiography 3. Cardiac MRI 4. Stress Echocardiography 13

Question 2 72 y.o. mild symptomatic female with moderate MS Your recommendation is 1. Cardiac CT 2. Coronary angiography 3. Cardiac MRI 4. Stress Echocardiography Case 2 14

Case 2 Mean PG: 5.7 mmhg Mean PG: 14 mmhg SPAP: 33 mmhg SPSP: 56 mmhg Summary Exercise induced pulmonary hypertension: SPAP: 56 mmhg Significant increase in MV gradient from baseline of 6 to 14 mmhg No wall motion abnormality Symptom was not increased Your recommendation is 15

Decision Carefully periodic monitoring 2017 updated ACC/AHA Guideline 16

Mitral stenosis Cut off Mean pressure gradient: 15 mmhg Systolic pulmonary artery pressure: 60 mmhg J Am Soc Echocardiogr. 2017 Feb;30(2):101 138. doi: 10.1016/j.echo.2016.10.016. Case 3 82 y.o. male With a history of aortic stenosis and coronary artery disease (post PCI to LAD). He noted a fatigue. 17

Case 3 LVEF: 25% Case 3 RCC LCC NCC 18

Case 3 Ao V: 3.0 m/sec Mean PG: 24 mmhg AVA: 0.8 cm 2 Stroke volume index: 34 ml/m 2 Question 3 82 y.o. mild symptomatic male with low gradient and low flow AS Your recommendation is 1. AVR 2. TAVI 3. Exercise echocardiography 4. Dobutamine echocardiography 19

Question 3 82 y.o. mild symptomatic male with low gradient and low flow AS Your recommendation is 1. AVR 2. TAVI 3. Exercise echocardiography 4. Dobutamine echocardiography Chart J Am Soc Echocardiogr. 2017 Feb;30(2):101 138. doi: 10.1016/j.echo.2016.10.016. 20

Dobutamine 20γ EF: 30% Mean PG: 41 mmhg AVA: 0.82 cm 2 Stroke volume index: 44 ml/m 2 ΔSV: 23% Pre Case 3 Peak 21

Chart Summary 82 y.o. mild symptomatic male with low flow low gradient AS Preserved contractile reserve: SVi 34 42 ml/m 2 (ΔSV>20%) True severe AS Your recommendation is 22

Decision Intervention (surgical AVR or TAVI) Aortic stenosis (low gradient) LV flow reserve True AS or pseud severe AS J Am Soc Echocardiogr. 2017 Feb;30(2):101 138. doi: 10.1016/j.echo.2016.10.016. 23

Problem of AVA in low gradient AS J Am Soc Echocardiogr. 2017 Feb;30(2):101 138. doi: 10.1016/j.echo.2016.10.016. Projected AVA Clavel MA et al. JACC Cardiovasc Imaging. 2013 Feb;6(2):175 83. 24

Projected AVA Yamada H. JACC Cardiovasc Imaging. 2014 Jul;7(7):641 9. Projected AVA Baseline DOB 20γ DOB AVA proj : 1.11 cm 2 AVA (cm 2 ) Peak velocity LVOT flow LVOT diameter 1.3 DOB AVA proj 1.2 DOB 1.1 Rest 1 0.9 0.8 0.7 150 200 250 Flow rate (ml/sec) Kusunose K, et al. Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e006690. 25

Projected AVA Baseline LPP AVA (cm 2 ) LPP AVA proj : 1.08 cm 2 Peak velocity LVOT flow LVOT diameter 1.3 DOB AVA proj 1.2 DOB 1.1 Rest 1 LPP LPP AVA proj 0.9 0.8 0.7 150 200 250 Flow rate (ml/sec) Kusunose K, et al. Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e006690. Projected AVA Event free survival (%) 100 Normal flow - low gradient Event free survival (%) 100 80 80 LPP-AVAi proj 0.72 60 60 40 20 Low flow - low gradient p =0.18 40 20 p <0.001 LPP-AVAi proj <0.72 0 0 5 10 15 20 25 Months Number at risk NF-LG 47 43 33 21 7 LF-LG 32 28 20 14 9 5 10 15 20 25 Number at risk AVAi proj 0.72 35 35 Months 28 20 11 AVAi proj <0.72 44 36 25 15 5 Kusunose K, et al. Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e006690. 26

Management of Low gradient AS Pibarot P, Clavel MA. Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e007035. Management of Low gradient AS Pibarot P, Clavel MA. Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e007035. 27

Aortic regurgitation Very few data in this field. Contractile reserve (>5% change in LVEF) J Am Soc Echocardiogr. 2017 Feb;30(2):101 138. doi: 10.1016/j.echo.2016.10.016. Take Home Message Stress echocardiography is Documenting functional capacity Determining severity of valve disease Timing of intervention Determining Prognosis 28

29